Clinical Trial Update: Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating stereotactic ablative radiotherapy (SABR) to pelvic and prostate targets in high-risk prostate cancer is active but not currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Prostate Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING